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HIV-1 is an RNA enveloped virus that preferentially infects CD4+ T lymphocytes and also
macrophages. In CD4+ T cells, HIV-1 mainly buds from the host cell plasma membrane.
The viral Gag polyprotein targets the plasma membrane and is the orchestrator of the
HIV assembly as its expression is sufficient to promote the formation of virus-like particles
carrying a lipidic envelope derived from the host cell membrane. Certain lipids are enriched
in the viral membrane and are thought to play a key role in the assembly process and
the envelop composition. A large body of work performed on infected CD4+ T cells has
provided important knowledge about the assembly process and the membrane virus lipid
composition. While HIV assembly and budding in macrophages is thought to follow the
same general Gag-driven mechanism as in T-lymphocytes, the HIV cycle in macrophage
exhibits specific features. In these cells, new virions bud from the limiting membrane of
seemingly intracellular compartments, where they accumulate while remaining infectious.
These structures are now often referred to as Virus Containing Compartments (VCCs).
Recent studies suggest that VCCs represent intracellularly sequestered regions of the
plasma membrane, but their precise nature remains elusive. The proteomic and lipidomic
characterization of virions produced by T cells or macrophages has highlighted the
similarity between their composition and that of the plasma membrane of producer
cells, as well as their enrichment in acidic lipids, some components of raft lipids and
in tetraspanin-enriched microdomains. It is likely that Gag promotes the coalescence of
these components into an assembly platform from which viral budding takes place. How
Gag exactly interacts with membrane lipids and what are the mechanisms involved in the
interaction between the different membrane nanodomains within the assembly platform
remains unclear. Here we review recent literature regarding the role of Gag and lipids on
HIV-1 assembly in CD4+ T cells and macrophages.
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THE ROLE OF GAG IN HIV ASSEMBLY
For proper assembly of newly synthesized virions, the different
viral and cellular components of HIV have to be addressed to
the assembly site. The polyprotein Gag is the major structural
orchestrator of the assembly process (Cimarelli and Darlix, 2002).
Beside Gag itself, GagPol polyproteins, the envelop (Env) gly-
coprotein (Checkley et al., 2011) and the viral genomic RNA
(gRNA) are recruited to the assembly site (Muriaux and Darlix,
2010; O’Carroll et al., 2013). In addition, host cell factors are
required for proper trafficking of the viral constituents, as well
as for virus assembly and budding. The nature of the host cell
factors and their incorporation into new virions can vary depend-
ing on the producer cell and thus may impact HIV-1 infectivity
(reviewed in Iordanskiy et al., 2013). Nevertheless, Gag expression
alone is sufficient for virus-like particle (VLP) production. Gag
is synthesized in the cytosol as a 55 kDa polyprotein comprising
several domains that are cleaved into independent proteins after
budding: the Matrix (MA), the Capsid (CA), the Nucleocapsid
(NC) and the p6 domain (Figure 1). Gag is targeted to the site of
budding where it interacts with the membrane and multimerizes.
Viral assembly requires Gag–Gag interactions that can occur at
different levels: MA–MA interactions uponMA-membrane inter-
actions, CA–CA interactions and NC–NC interactions via the
genomic RNA (gRNA) (Figure 1). The gRNA is recruited to the
nascent viral particle via a selective interaction between its Psi
encapsidation sequence and the NC domain of Gag (Muriaux and
Darlix, 2010; Lu et al., 2011). The formation of VLPs at the plasma
membrane (PM) of infected cells requires the myristoylation of
Gag (Bryant and Ratner, 1990; Resh, 2005) and the presence
of a highly basic region (HBR) in the N-term of MA for Gag
anchoring into the cell membrane lipid bilayer (Chukkapalli and
Ono, 2011). Other amino acids in the vicinity of MA/membrane
interface could also be involved but have not yet been described.
In this review, we will focus on the Gag-driven viral assembly
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FIGURE 1 | HIV Gag assembly at the molecular level. The viral HIV-1 Gag
protein is composed of several domains: the matrix MA is myristyolated in its
N-term and contains a highly basic region (HBR) that binds the lipidic
membrane or the viral genomic RNA, the capsid CA that favors Gag–Gag
multimerization, the NC domain that selects the viral genome and favors Gag
multimerization, its C-term p6 domain that binds ESCRT proteins requires for
retroviral budding and particle release and 2 spacer peptides, sp2 and sp1
required for HIV assembly and morphogenesis. In the cytosol, Gag is a dimer
and adopts a compact shape in which the viral genomic RNA is in interaction
with the NC and MA domains. At the cell membrane, the MA domain of Gag
targets, via its HBR, the inositol head of the PI(4,5)P2 located at the inner
leaflet of the PM and its myristate anchors the lipid bilayer. The MA domain
of Gag can recruit several PI(4,5)P2, and PS, thanks to its basic residues. This
should allow the recruitment of other Gag molecules due to Gag electrostatic
membrane interaction concomitant with Gag multimerisation, via CA, and NC
on the viral RNA. This process should trigger the formation of ALEM (acidic
lipid enriched microdomains) in the cell membrane. These ALEM containing
Gag could now join together to create higher ordered microdomains of Gag
and/or microdomains containing other proteins such as Env, or tetraspanins,
integrins or other cell factors found in the viral envelope. The coalescence of
these microdomains containing several Gag multimers creates the HIV
assembly platform.
process in HIV-1-infected T cells and macrophages. The recog-
nition between Gag preassembling complexes and the Env will
not be developed here and has been reviewed by others (Checkley
et al., 2011).
HIV PRODUCING CELLS: CD4+ T-CELLS AND MACROPHAGES
HIV-1 mainly infects activated CD4+ helper T cells in vivo (Freed
and Martin, 2001). Most infected activated T cells produce large
amounts of new virions and die of apoptosis. A minority acquire
a memory phenotype and progress to latently infected cells,
able to survive for decades in the absence of virus production
(Kuritzkes D.R., 2007). Upon arrest of therapy, these cells can
be activated and participate in the rebound in HIV-1 titers, and
are therefore important reservoirs of the virus. HIV-1 assembly,
budding and release from CD4+ T cells occurs mainly at the
plasma membrane (PM). In polarized CD4+ T-cells, HIV com-
ponents for assembly, such as Gag and the genomic RNA are
localized at the uropod membrane as shown by live cell fluores-
cence microscopy (Hatch et al., 2013; Llewellyn et al., 2013). An
exception among T cells are the chronically-infected MOLT lym-
phoblasts in which infectious HIV-1 are found in intracellular
compartments (Grigorov et al., 2006).
Macrophages are the other main cellular target of HIV. They
play important roles during HIV infection and AIDS progression
due to their specific features (Koppensteiner et al., 2012). Infected
macrophages have been found in all tissues such as the vaginal
mucosa, the brain and the lung (Gartner et al., 1986; Shen et al.,
2009; Jambo et al., 2014), where they remain infectious for long
periods of time (Sharova et al., 2005). In contrast with T cells,
macrophages resist HIV-induced cytopathic effects for months
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in vitro as well as in vivo (Koppensteiner et al., 2012). They
accumulate virions in large intracytoplasmic vacuoles (Orenstein
et al., 1988), that are often referred to as VCCs (Virus-Containing
Compartments) (Figure 2C) or IPMCS (Intracellular Plasma
Membrane-Connected Compartments) (Mlcochova et al., 2013).
Electron microscopy studies of infected macrophages revealed
budding profiles at the limiting membrane of the VCC and the
presence of immature virion in the lumen of the compartments,
demonstrating that VCCs represent the site of HIV assembly
in macrophages (Orenstein, 1998; Raposo et al., 2002; Pelchen-
Matthews, 2003; Jouve et al., 2007). Newly formed viral particles
accumulate in the VCC lumen and VCCs tend therefore to fill
up with time (Gaudin et al., 2013). Early on, VCCs were classi-
fied as late endosomes or multivesicular bodies because of their
endosomal markers and their morphology (Raposo et al., 2002;
Pelchen-Matthews, 2003). However, they were later shown to be
inaccessible to BSA-gold, devoid of EEA1 (Deneka et al., 2007;
Jouve et al., 2007) and to possess a neutral luminal pH (Jouve
et al., 2007), suggesting that they were not true endosomes. The
lumen of the VCCs can be transiently accessible to extracellular
molecules (Deneka et al., 2007; Berre et al., 2013; Gaudin et al.,
2013) possibly through direct tubular connections to the PM
(Welsch et al., 2007; Bennett et al., 2009). VCCs are now regarded
as specialized, intracellular sequestered portions of the PM, possi-
bly with dynamic connections to the extracellular milieu (Gaudin
et al., 2013; Mlcochova et al., 2013), for reviews see Benaroch et al.
(2010) and Tan and Sattentau (2013).
The two main cellular targets of HIV, CD4+ T cells and
macrophages, exhibit very different morphology, function and
physiology. The assembly site of HIV in both cell types appears
different : the PM of small round T-lymphocytes versus the
internal convoluted membrane meshwork of large macrophages
(Figure 2). This raises the question of the cell specificity for
the mechanism(s) underlying virus assembly and for the lipid
FIGURE 2 | Scheme and images of HIV assembly at the cellular level. (A)
Membrane cell proteins and lipid composition that are found in the virus
membrane issued from CD4+ T cell lines or at polarized T cell uropods. From
Brügger et al. (2006); Chan et al. (2008); and Lorizate et al. (2013) for the virus
lipid membrane composition. From Grigorov et al. (2006, 2009); and Nydegger
et al. (2006) for the virus membrane protein composition. From Llewellyn et al.
(2013) for theGag containing T cell uropodmicrodomains. (B)HIV-1 assembly in
chronically infected MOLT cells as shown by immunofluorescence confocal for
Gag, Env and the cell CD63 tetraspanin (a) and electron(b) microscopy. (a) HIV-1
infected MOLT cells were fixed in 3% PFA and stained for Gag with an
anti-MAp17, anti-gp120, and anti-CD63 for immunofluorescence confocal
imaging. (From D. Muriaux lab.) (b) HIV-1 infected MOLT cells were fixed with
2.5% glutaraldéhyde, embedded and thin-sectioned for electron microscopy
imaging, as in Grigorov et al. (2009) (From P. Roingeard lab.). (C) The scheme
shows the cell membrane proteins and lipids found associated with the viral
membrane of HIV-1 issued frommonocyte derived macrophages. From
Chertova et al. (2006); Chan et al. (2008); Lorizate et al. (2013). (D)HIV assembly
in VCC in MDM as shown by immunofluorescence confocal microscopy and
electron microscopy. MDM 4 days post-infection with WT HIV-1 NL-AD8,
stained by immunofluorescence for CD44 (green), Gag (red), and CD81
(magenta). The nucleus is stained with DAPI. Bar: 20µm. CD44 and CD81 are
present at the plasma membrane but also in intracellular compartments were
they co-localize with Gag in infected MDM. (From P.Benaroch lab). For electron
microscopy, kindly provided by Mabel Jouve, MDM 15 days post-infection with
WT HIV-1 NL-AD8 were fixed, embedded in epon, and ultrathin sections were
contrasted with uranyl acetate and lead citrate. Bar: 2µm.
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membrane composition of produced virions. Most studies per-
taining to the role of Gag and lipids in HIV assembly in
live cells used T-cell lines or adherent epithelial cell lines,
with only few results confirmed in human primary T-cells or
monocyte-derived macrophages (MDM), the classical culture
model for macrophages. However, we will see below that most
observations and mechanistic hypotheses regarding the role of
membrane lipids in HIV assembly can apply for T-cells and
macrophages.
COMPOSITION OF HIV ASSEMBLY SITES IN T CELLS AND
MACROPHAGES
TETRASPANIN-ENRICHED MICRODOMAINS
In primary T-cells and T-cell lines, Gag accumulates in specific
domains of the PM containing the tetraspanins CD9, CD63,
CD81, and CD82 that are referred to as Tetraspanin Enriched
Microdomains (TEM) (Booth et al., 2006; Grigorov et al., 2006;
Nydegger et al., 2006). These tetraspanins are present in sub-
domains of the PM of HIV-infected T cells together with Gag
and Env as shown by immunofluorescence analysis and immuno-
precipitation (Jolly and Sattentau, 2007; Grigorov et al., 2009)
(Figures 2A,B). In addition, virions released and purified from
these cells are associated with the same tetraspanins (Grigorov
et al., 2009). HIV-infected and polarized T-cells possess “specific
uropod-directed microdomains” that contain PSGL-1 (P-Selectin
Glyco- protein Ligand 1), CD43 and CD44 (Figure 2A) where
Gag localizes due to its NC and MA regions (Llewellyn et al.,
2013).
In infected macrophages, TEMs are also a component of the
assembly site of HIV and the same tetraspanins are enriched
at the VCC limiting membrane as revealed by immunofluo-
rescence and electron microscopy (Figure 2C) (Deneka et al.,
2007; Gaudin et al., 2013; Mlcochova et al., 2013). This is also
reflected by the composition of virions produced bymacrophages,
which harbor several tetraspanins (CD9, CD81, CD82, CD53,
CD63) as assessed by mass spectrometry (Chertova et al., 2006).
These virions also contain other proteins enriched in the VCCs,
such as CD44, CD18, and CD11b, further highlighting that the
envelope of the virus derives from the membrane of the VCC
(Figures 2C,D). Interestingly, the limiting membrane of the VCC
as well as the virions present in the VCC of infected macrophages
contains the scavenger receptor CD36, which represents so far
the first macrophage specific marker of the viral assembly site as
compared to T lymphocytes (Berre et al., 2013).
VIRUS MEMBRANE LIPID COMPOSITION
Lipidomic analysis of HIV virions has provided important infor-
mation regarding the nature of the membrane domains where the
viral budding takes place (Aloia et al., 1993; Brügger et al., 2006;
Chan et al., 2008; Lorizate et al., 2013). Early work revealed that
HIV-1 and HIV-2 virions were enriched in cholesterol when com-
pared to the PM of producer cells H9 T-cells, suggesting that HIV
buds from specific domains of the PM (Aloia et al., 1993). Later,
Chan et al. showed that virions from T cells were mainly enriched
in acidic lipids (PI, PIP2, PS), GM3, cholesterol and SM (Chan
et al., 2008), a composition close to that of “rafts-like” domains.
However, the HIV assembly site exhibits some differences with
these domains since the GM1 raft lipid and the CD55 raft protein
were only transiently found trapped in viral assembly sites, at least
in adherent cell lines (Krementsov et al., 2010). The dynamics of
other lipids have not been studied during Gag assembly in living
primary host cells and should be investigated in order to validate
the role of lipids in HIV assembly and budding or the role of Gag
in the formation of lipidic domains. A recent study done on MT4
T cells showed an enrichment in PS, PI, pl-PE, PG, and hexCer
but not Cholesterol in the virus particles when compared to the
PM (Lorizate et al., 2013). This suggested that the HIV envelope
composition can vary as a function of the membrane composi-
tion of the producer cell or depends on experimental conditions,
such as techniques used to purify the PM (Lorizate et al., 2013)
or to separate viral particles from microvesicles shed by the cells
(Chertova et al., 2006; Chan et al., 2008; Coren et al., 2008).
However, a constant observation is the enrichment in glycosphin-
golipids (Cer or SM) and/or Cholesterol that could locally order
the virion bud membrane and in an acidic phospholipid (PI,
PIP2, or PS) that is required for Gag membrane recruitment (see
below). Figure 2A summarizes the lipidic and proteic enrichment
of HIV envelope composition in T-lymphocytes and MDM.
Only one study so far investigated the lipidomic composition
of HIV virions produced by macrophages (Chan et al., 2008).
It showed that, when compared to the PM of the macrophages,
viral particles are enriched in phosphorylated derivatives of phos-
phatidylinositol (PIP, PIP2), the glycosphingolipid GM3 and to
a lesser extend sphingomyelin but not in cholesterol. HIV viri-
ons from macrophages are also enriched in ceramide, which may
be a sign of coalescence of other lipid nanodomains into big-
ger domains at the level of the assembly platform. Importantly,
Chan et al. compared HIV virions produced by T-cells and
macrophages. Both types of virions exhibited a very similar lipidic
composition while the global PM composition was different in
macrophages as compared to T-cells (Chan et al., 2008). These
data suggest that HIV is able to reach or to create a favorable
lipidic environment containing the components necessary for its
assembly and budding in both cell types.
Thus, in macrophages as in T cells, HIV assembles at and
buds from specific membranes enriched in acidic lipids, sterols
and/or glycosphingolipids (reviewed in Kerviel et al., 2013).
Nevertheless, the fine mechanism underlying Gag targeting to
such PM domains remains unclear.
GAG TARGETING TO THE VIRAL BUDDING SITE
Gag synthesis occurs in the cytoplasm where it is myristoylated
(Bryant and Ratner, 1990). Gag selectively interacts with the
genomic RNA from which it has been translated (de Breyne et al.,
2013). Then Gag is targeted to the cell PM (Kutluay and Bieniasz,
2010) either by transport as minimal Gag-RNA complexes or sim-
ply by diffusion. At this point, cytosolic Gag is probably in a low
dimerization state (Kutluay and Bieniasz, 2010) and in a compact
conformation likely in interaction with the viral RNA (Figure 1)
(Datta et al., 2007; Munro et al., 2014) and should reach the
plasma membrane for assembly.
GAG INTERACTIONWITH THE PLASMAMEMBRANE: A ROLE FOR
PI(4,5)P2
The MA domain of Gag can bind lipids at the inner surface
of the cell PM where Gag multimerizes, thanks to its myristate
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(Bryant and Ratner, 1990) and its Highly Basic Region (HBR)
(Ono, 2009). Based on biophysical experiments, conformations of
a monomeric form of HIV-1 Gag were analyzed in solution, and
the results revealed that Gag can adopt a compact conformation
(Datta et al., 2007). Single molecule FRET experiments and FCS
revealed that upon assembly into VLP, Gag undergoes a confor-
mational transition from compact to an extended form (Munro
et al., 2014). It has been proposed that upon its interaction with
membrane phospholipids and during its multimerization, Gag
adopts an extended conformation, similar to the one observed
in immature virus. This process is triggered by the interaction
of the HBR at the N-ter of MA with the PM PI(4,5)P2 phos-
pholipid (Ono et al., 2004a; Saad et al., 2006; Chukkapalli et al.,
2008). In addition, the genomic RNA and the PI(4,5)P2 are prob-
ably in competition for the binding of the MA HBR (Chukkapalli
et al., 2010). This suggests that under its compact conformation,
Gag is able to interact with the genomic RNA through the MA
HBR as well as through the NC and as soon as Gag is in the
vicinity of a PI(4,5)P2 containing membrane, it switches to the
extended conformation which the HBR interacts with PI(4,5)P2.
Thus, it appears thatMA-membrane binding requires the anchor-
ing of the N-term MA myristate in the membrane lipid bilayer, a
change of Gag conformation from a compact to an extended rod-
like shape, and the electrostatic interaction between the charged
sugar head of phospholipids (such as PI(4,5)P2 and PS) and the
MA HBR (Figure 1).
PI(4,5)P2 facilitates Gag-membrane binding to the plasma
membrane in T cells and is required for efficient virus release
(Monde et al., 2011). However, in T cells engineered to express
low levels of PI(4,5)P2, the virus particle production can still
occur, suggesting that the MA domain of Gag can probably inter-
act with other charged acidic lipids, such as PS, as reported
by lipidomic analysis of HIV virions (Lorizate et al., 2013).
Interestingly, in these T cells, the virus adapted to compensate
the lack of PI(4,5)P2 by a “charged” mutation in MA (L74R)
that enhances virus infectivity (Monde et al., 2011). The role for
PI(4,5)P2 dependence for virus release remains unclear and may
involve other cellular lipids or proteins or a cell signaling cascade.
This interaction regulates the proper targeting of the viral com-
ponents to the assembly site. Indeed, mutations of the HBR MA
domain induce re-localization of Gag from the PM to CD63+
intracellular compartments in HeLa and in T cells (Ono et al.,
2004b).
In macrophages, both WT and MA-mutant Gag co-localize
with a subpopulation of CD63+ compartments (Ono et al.,
2004b; Gousset et al., 2008). However, it is unclear whether these
CD63+ compartments represented true VCCs, since few other
VCC specific markers were used in these studies (Ono et al.,
2004a; Gousset et al., 2008). Importantly, PI(4,5)P2 was detected
at the limiting membrane of intracellular CD81+, CD44+, or
Gag+ compartments and at the PM in infected macrophages
(Mlcochova et al., 2013). Together, these results suggest that the
basic region of the MA domain may contribute to Gag targeting
to the VCC through phospholipid binding, in MDM as in T-cells.
In addition, other unknown factors may be required to regulate
this targeting (Ono et al., 2004b; Gousset et al., 2008; Mlcochova
et al., 2013).
OTHER RETROVIRUSES
The mechanism by which the HBR of retroviral MA (Murray
et al., 2005) binds the PM PI(4,5)P2 phospholipid is likely to be
general for many retroviruses such as HIV-1 (Ono et al., 2004a;
Saad et al., 2006; Chukkapalli et al., 2008), HIV-2 (Saad et al.,
2008), EIAV (Chen et al., 2008), MLV (Hamard-Peron et al.,
2010), and MPMV (Prchal et al., 2012). It is controversial for
Rous Sarcoma Virus (RSV) as some authors have found that in
vitro RSV MA binding to membranes requires acidic lipids like
PS but not PI(4,5)P2 (Chan et al., 2011). In addition, no effect of
the phosphatase-mediated depletion of PI(4,5)P2 was reported on
RSV Gag cellular localization and VLP production. In contrary,
another study described, in a cellular context, that the presence of
PI(4,5)P2, and/or PI(3,4,5)P3, is required for RSV Gag targeting
to the PM and for virus release in a NC-dependent Gagmultimer-
ization manner (Nadaraia-Hoke et al., 2013). In the case of EIAV,
MA has greater affinity for PI(3)P than PI(4,5)P2, as shown in
vitro by NMR lipid titration. Interfering with the metabolism of
PI(3)P, but not of PI(4,5)P2, prevents EIAV assembly and release,
indicating a slight difference of PI recognition for this retrovirus
compared to others (Fernandes et al., 2011). Only one retroviral
Gag seems to make an exception, as HTLV-1 MA does not require
PI(4,5)P2 interaction to trigger Gag targeting and membrane
binding (Inlora et al., 2011).
GAG-DRIVEN CONSTRUCTION OF THE ASSEMBLY
PLATFORM
Differences in lipid composition between HIV envelop and the
host cell PM suggest, as mentioned earlier, that the virus buds
from a specific Gag-containing membrane domain. Gag could
either bind these pre-formed lipidic and proteic microdomains at
the PM, or induce their formation by segregating the components
through electrostatic interactions and Gag multimerization.
ACIDIC LIPID ENRICHED MICRODOMAINS (ALEM)
We hypothesize that Gag alone or minimal Gag-RNA complexes
are targeted to the PM not only by the electrostatic interaction
of the HBR region of MA with the PI(4,5)P2/PS lipids, but also
by Gag multimerization via its CA/CA interaction and NC/RNA
interaction. The stabilization of the MA—membrane interaction
appears to rely on the insertion of the myristate into the lipid
bilayer (Charlier et al., 2014), as well on the interaction of the
HBR motif with the sugar head of PI(4,5)P2 and consequently
on Gag multimerization. Other cellular cofactors of membrane
microdomain formation such as cortical actin (unpublished data)
or tetraspanin web (Thali, 2009) could contribute to the stabi-
lization of Gag multimers at the cell PM. We propose that upon
Gag—membrane interaction, Gag multimerization triggers the
formation of acidic lipid enriched microdomains (ALEM) at the
inner leaflet of the cell membrane (Kerviel et al., 2013) as it has
been shown by dynamic coarse grained modeling of HIV-1 MA
anchoring in a lipidic membrane (Charlier et al., 2014). The gen-
eration of ALEM by Gag itself is likely due to lipid sequestering
induced by electrostatic interaction as reported before for other
cellular proteins (van den Bogaart et al., 2011). This early event
certainly generates nanodomains smaller than the size of a virus
bud and different from rafts. Then viral assembly could propagate
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either by expansion of these nanodomains or by coalescence of
several Gag-enriched membrane nanodomains to form the final
viral bud.
MICRODOMAINS COALESCENCE
The formation of ALEM by higher order Gag multimer forma-
tion could then drain other microdomains of the external leaflet
of the cell PM such as tetraspanin-enrichedmicrodomains (TEM)
or rafts, that contain other lipids like Ceramide, Cholesterol,
Sphingomyelin and proteins such as tetraspanins (Yanez-Mo
et al., 2009) or the embedded Env glycoproteins (Checkley et al.,
2011). Coalescence of nanodomains has been reported for Gag
with “rafts-like” membrane domains and TEM in Hela cells
(Krementsov et al., 2010; Hogue et al., 2011). This model is
supported by the work of Ono and co-workers, with antibody-
mediated copatching and FRET assays (Hogue et al., 2011) con-
ducted on adherent Hela cells expressing HIV-1. Interactions
between Gag and the inner leaflet of PM appear to induce the
coalescence of TEM and lipid raft at the viral assembly site. This
is also in line with a model where Gag does not associate with
pre-existing virus-sized microdomains organized by cellular fac-
tors, but rather functions as a microdomain-organizing factor to
create novel virus-induced microdomains in a stepwise manner
during the course of assembly (Krementsov et al., 2010; Hogue
et al., 2011; Kerviel et al., 2013).
In this model (Figure 1), Gag recruits PI(4,5)P2 upon its
binding to the membrane, then its multimerization induces the
formation of ALEM in the inner leaflet of the membrane, which
further triggers the coalescence of other nanodomains of the outer
leaflet of the membrane, such as lipid rafts and TEM (Kerviel
et al., 2013; Charlier et al., 2014).
In polarized CD4+ T cells, such advanced studies have not
been done, but Ono and co-workers have shown that HIV-1 Gag
assembly occurs in uropod-specific microdomains and that this
Gag localization depends on higher order NC dependent multi-
merization of Gag (Llewellyn et al., 2010), in agreement with the
model proposed above. In macrophages, studies that pertain to
the molecular interactions driving the construction of the assem-
bly platform are still lacking. Considering that Gag assembly is
a sequential process and several molecules are required to form
higher ordered microdomains, Gag-acidic lipid nanodomains
certainly fuse together. In addition, they can get enriched in other
lipids via the coalescence with other surrounding nanodomains
containing cell membrane proteins such as CD81 tetraspanin
(Nydegger et al., 2006; Grigorov et al., 2009) or other lipids from
the upper bilayer, such as SM and GM3 (Chan et al., 2008).
A ROLE FOR CHOLESTEROL?
Gag could directly sense other lipids than PIP2, like cholesterol
(Dick et al., 2012). Depletion of cellular cholesterol markedly and
specifically reduced HIV-1 particle production (Ono and Freed,
2001). Drug-induced redistribution of the cholestorol from the
PM to endosomes led to relocation of Gag from the PM to
intracellular MVB-like CD63+ compartments (Lindwasser and
Resh, 2004), suggesting a possible role for cholesterol in Gag tar-
geting to assembly sites. However, Gag contains no cholesterol
binding motif, unlike other viral proteins with roles in entry or
morphogenesis (Schroeder, 2010). Several studies have proposed
that HIV-1 regulates the levels of cellular cholesterol, presumably
to achieve efficient viral egress. A Nef-induced decrease of the
ABCA1-dependent efflux of cholesterol to the Apolipoprotein A1
has been reported (Mujawar et al., 2006; Morrow et al., 2010),
leading to increased cholesterol in lipid rafts (Cui et al., 2012).
This mechanism is likely involved in HIV-associated dyslipidemia
as observed in macaques infected by SIV (Asztalos et al., 2010).
However, Nef had no impact on virus content in cholesterol in
MT4 T cells (Brügger et al., 2007). Thus, the role of cholesterol in
virus budding and infectivity remains to be assessed.
MODULATION OF CALCIUM SIGNALING IN HIV-1 ASSEMBLY
AND RELEASE
The PI(4,5)P2 represents 1–2% of the total phospholipids at the
inner leaflet of the cell PM, and it is a key regulator of several
cellular processes taking place at the cell PM, such as endo-
cytosis, exocytosis, cytoskeleton attachment and activation of
enzymes (reviewed in McLaughlin and Murray, 2005). PI(4,5)P2
anchors cellular proteins to the PM through Pleckstrin Homology
domains that can activate different ion channels located at the PM
(Suh and Hille, 2005). PI(4,5)P2 is also the precursor of second
messengers such as inositol(1,4,5)triphosphate (IP3) or diacyl-
glycerol (DAG). IP3 can regulate release of Ca2+ from internal
storages; DAG can activate the protein kinase C (PKC). In the
course of HIV assembly and budding, it was suggested a role for
intracellular Ca2+ increase in boosting virus release (Grigorov
et al., 2006; Perlman and Resh, 2006). In addition, calmodulin,
CaM, a regulator of intracellular Ca2+ concentration, interacts
with the N-terminal domain of HIV-1 MA as shown, in vitro,
by NMR and biochemical experiments (Samal et al., 2011; Vlach
et al., 2014). This interaction depends on Ca2+ and is able to
induce the MA myristate exposure and an extended MA confor-
mational change (Chow et al., 2010; Ghanam et al., 2010; Taylor
et al., 2012). In cells, Carter and co-workers have shown that HIV-
1 Gag induces Ca2+ release from intracellular compartments,
probably from the endoplasmic reticulum, by activating the cas-
cade PI(4,5)P2-PLC-IP3-IP3R (Ehrlich et al., 2010; Ehrlich and
Carter, 2012). IP3 receptor and Sprouty2, also regulators of Ca2+
signaling, are required for HIV Gag particle release (Ehrlich et al.,
2011). Thus, it appears that in addition to the requirement of the
PI(4,5)P2 as a co-factor for HIV-1Gag targeting to the PM, related
lipid metabolism and second messengers or Ca2+ signaling are
involved in virus particle release. These findings open a new door
in the regulation of HIV-1 particle production.
CONCLUSION
CD4+ T lymphocytes and macrophages are very different in size,
shape and immune functions. The HIV-1 virions produced by
CD4+ T cells or macrophages carry specific lipids and cellu-
lar proteins, incorporated during virus assembly. The cellular
components identified so far appear quite similar in both cell
types, suggesting that, at the molecular level, Gag-membrane
interaction with lipids (and proteins) occurs in a similar way
during assembly. This is in line with a model where Gag con-
tains most of the determinants for selecting or creating the best
lipidic environment for viral bud formation. We propose that
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Gag multimerization will generate an assembly platform contain-
ing specific lipid membrane nanodomains through its interaction
with selective lipids. The creation of this assembly platform in
the inner layer of the PM, probably recruits the nanodomains
enriched in other proteo-lipid domains present in the upper layer.
Finally, all the components involved in the PM structure and
signaling (i.e., lipid metabolism, calcium mobilization and/or
actin cytoskeletal reorganization) may contribute to the assembly
process of enveloped viruses. Deciphering the complex process
of assembly, will require the identification of additional cellular
proteins that have yet to be discovered.
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